|
Re: Side Effects of Ending Herceptin
I'm not sure exactly which vaccine he is talking about. He did say they are involved in two studies. One using a placebo against the vaccine and the other which he said he preferred for me using different dosages and additional agents added to increase the effectiveness. He said that you had to finished with the initial treatments and be disease free to qualify. He wasn't sure if the study was full or not. I will see him again on the 20th of this month and will learn more. I will be sure to share the info.
Thanks for you reply.
Sandra
__________________
Diagnosed: 7/25/08 ~ age 63, no family history
Surgery: 8/14/08 Bilateral mastectomy; tumor left breast, node dissection; right prophylactic with expanders: 1/12/10 latisimuss dorsi flap on left side: 9/22/10 implants in
Pathology Report: ER/PR-; HER2+ (3+); Grade 3, StageIII; 3cm tumor plus 21/21 lymph nodes positive; 5cm DCIS
Chemo: A/C; Taxol/Herceptin/Tykerb; phase II study at Mayo adding Tykerb for early stage
Radiation: 25 rads
Vaccine: Walter Reed GP2/AE37 vaccine study ~ last booster 9/17/2012
|
Hybrid Mode
